PHYTOCHEMICAL SCREENING AND EVALUATION OF ANTIOXIDANT PROPERTIES OF SECONDARY METABOLITES IN AQUEOUS EXTRACTS OF FICUS THONNINGII BLUME TESTED ON WISTAR RATS

Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2019, Vol 6, Issue 2

Abstract

Introduction: Traditional medicine methods have had a very long history to treat every sort of health disorder. The World Health Organization estimates that around 80 % of the world population in developing countries relies on traditional plant medicines for primary health care needs, of which a major proportion corresponds to plant extracts or their active principles. Plants and herbs have been used since ancient times to treat different gastrointestinal illnesses, including peptic ulcers. Objective: To identify the major classes of secondary metabolites and evaluate the antioxidant property of the aqueous extracts of Ficus thonningii. Methods: The phytochemical screening of the extracts was done using the Odebiyi and Sofowora method. Various biochemical parameters such as the Malondialdehyde (MDA), Catalase, Glutathione, Superoxide dismutase (SOD), Xanthine Oxidase (XO), were quantified using standard regulatory techniques. Results: The phytochemical screening of the extract of the F. thonningii stem bark showed the presence of the sapononins, quinones, coumarins, catechic tannins, phlobotanins, anthocyanins, flavonoids and betacyanes. The extract resulted in a non-significant increase of SOD, Catalase and glutathione in the preventive and curative activity. There was a dose-dependent significant decrease in MDA P<0.05. The MDA content was higher in the group receiving the extract 500 mg/Kg, omeprazole and healthy animals, but lower in the negative control group. Conclusion:The phytochemical screening of the extract of the bark showed the presence of the saponins, quinones, coumarins, catechic tannins, phlobotanins, anthocyanin, polyphenols, flavonoïds and betacyanes. The extract resulted in a non-significant increase of SOD, Catalase and glutathione with a dose dependent decrease in MDA. The administration of this extract with 2000 mg/Kg dose was well tolerated with no lethality observed.

Authors and Affiliations

Charles Ntungwen Fokunang

Keywords

Related Articles

AN UPDATE ON TREATMENT OF ALZHEIMER DISEASE- A LITERATURE REVIEW

Alzheimer’s disease represents an enormous global burden in terms of human suffering and economic cost. It is the most common cause of dementia all over the world. The pathological hallmarks of Alzheimer's disease are am...

SYNTHESIS AND CHARACTERIZATION OF CELLULOSE GRAFTED MALEIC ANHYDRIDE AND SUBSTITUTED IT WITH AMOXICILLIN

In this research the structural modification of cellulose was carried out with maleic anhydride (H) as a spacer by using ceric ammonium nitrate (CAN) as an initiator, and grafted copolymer was substituted with amino drug...

SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF NEW INDOLOQUINOLINE – BIOTIN HYBRIDS

A series of indoloquinoline- biotin hybrids conjugates 7a-f were designed and synthesized in good yields to improve and develop higher potency and selective anti-tumor agents. Their antiproliferative evaluation activitie...

OPTIC COHERENCE TOMOGRAPHY RESULTS IN PATIENTS WITH BEHÇET’S DISEASE

Significance: Retina is considered to be an easily traceable part of the brain. Even though the retina does not contain myelin, it is an ideal model of neuronal tissue where degeneration of the ganglion cell neurons and...

DEVELOPMENT AND EVALUATION OF CONTROLLED RELEASE LOSARTAN POTASSIUM FORMULATION USING DIFFERENT POLYMERS

The present study was undertaken to develop and evaluate controlled release formulations of Losartan potassium by using different polymers in various drug to polymer ratios [1:1, 1:2 &1:3]. Polymers used were Eudragit RS...

Download PDF file
  • EP ID EP672607
  • DOI -
  • Views 165
  • Downloads 0

How To Cite

Charles Ntungwen Fokunang (2019). PHYTOCHEMICAL SCREENING AND EVALUATION OF ANTIOXIDANT PROPERTIES OF SECONDARY METABOLITES IN AQUEOUS EXTRACTS OF FICUS THONNINGII BLUME TESTED ON WISTAR RATS. European Journal of Pharmaceutical and Medical Research, 6(2), 121-129. https://www.europub.co.uk/articles/-A-672607